Her2 amplification by next-generation sequencing to identify her2-positive invasive breast cancer with negative her2 immunohistochemistry

HIGHLIGHTS

• who: Laura Morsberger from the Department of Pathology, Cancer Genetics Laboratory, Cytogenetics Medicine and Pathology, Johns Hopkins University School of Medicine, Ashland Ave, Suite, Baltimore, MD, USA have published the paper: HER2 amplification by next-generation sequencing to identify HER2-positive invasive breast cancer with negative HER2 immunohistochemistry, in the Journal: (JOURNAL) of April/30,/2022
• what: HER2-positive invasive breast carcinomas with negative HER2 IHC results and positive HER2 FISH results are usually concealed by our current HER2 test strategy with HER2 IHC testing as a screening test for all newly diagnosed breast cancer . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.